Fachliteratur Gastroenterologie: Neoplasien der Gallenwege

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Gallenwege » Neoplasie

17. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Fachliteratursuche

Gallenwege

Cholezystitis - Cholelithiasis

Schrift:

Seite 1 von 876


	Artikel 1 - 20 / 17506

	Intracholecystic papillary neoplasm with associated invasive carcinoma mimicking adenomyomatosis. BMJ Case Rep Omameuda T, Miki A, Mochizuki M, Tahara M, Kitabayashi H, Shiozawa M, Kawai S, Koizumi M. PMID: 42463170 [PubMed - indexed for MEDLINE]
	Routine Lymph Node Dissection in the Surgical Treatment of Primary Liver Tumors: a Systematic Review and Meta-Analysis. J Gastrointest Cancer Buisman BL, Goense L, Hoogwater FJH, Nijkamp MW, Borel Rinkes IHM, Hagendoorn J, Oor JE. PMID: 42461487 [PubMed - indexed for MEDLINE]
	ConLymphNet: A Generalizable Region-Constrained Deep Learning Architecture for Precise Abdominal Lymph Node Segmentation Across Cancer Types. JCO Clin Cancer Inform Gupta P, Saini S, Aggarwal A, Gulati A, Patkar S, Dutta N, Jeswani S, Kakkar L, Bose K, Prakash G, Yadav TD, Kaman L, Irrinki S, Singh H, Khosla D, Shah N, Choudhari A, Goel M, Kapoor R, Gupta R, Dutta U, Arora C. PMID: 42456080 [PubMed - indexed for MEDLINE]
	Antibiotic exposure and indication-specific corticosteroid use differentially modulate outcomes of immune checkpoint inhibitor therapy in hepatobiliary malignancies. Front Immunol Yang J, Wang W, Jiao M, Zhang Z, Lei S, Lan N, Chen M, Wang Z, Hui B, Bakhat TID, Ren J. PMID: 42445194 [PubMed - indexed for MEDLINE]
	Immunotherapy plus chemotherapy in advanced biliary tract cancers: pros and cons. Expert Rev Gastroenterol Hepatol Brar G, Valle JW. PMID: 42437561 [PubMed - indexed for MEDLINE]
	Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers. JCO Precis Oncol Shah P, Peersen A, Sahai V, Mahipal A, Naleid N, Borad M, Bekaii-Saab T, Sonbol MB, Majeed U, Babiker HM, O'Donnell CDJ, Malla M, Gupta G, Conboy CB, Fonkoua LK, Washburn LA, Halfdanarson TR, Peterson N, McWilliams RR, Carr RM, Graham RP, Starlinger P, Smoot R, Warner S, Ilyas SL, Gores GJ, Roberts L, Heimbach J, Ou FS, Tran NH. PMID: 42430699 [PubMed - indexed for MEDLINE]
	Biliary neuroendocrine tumors: a narrative review of current diagnostics and management strategies. Chin Clin Oncol Darapu HB, Manne A, Kasi A, Paluri RK. PMID: 42425778 [PubMed - indexed for MEDLINE]
	Development and Validation of a Cytochrome C Oxidase Subunit 6B2-Based Risk Model for Cholangiocarcinoma Recurrence. JCO Precis Oncol Chen M, Xie X, Wang J, Zhang L, He Y, Yang J, Tian J, Zhao D. PMID: 42418741 [PubMed - indexed for MEDLINE]
	Inflammation and RNA-Related Polymorphisms in Resected Cholangiocarcinoma: Prognostic Associations in Intrahepatic and Perihilar Tumors. J Gastrointest Cancer Wang G, Liu D, Al-Masri TM, Lueong SS, Siveke JT, Luedde T, Vondran FWR, Lurje G, Neumann UP, Heij LR, Bednarsch J. PMID: 42418091 [PubMed - indexed for MEDLINE]
	Comparative efficacy of interventions for jaundice in hilar cholangiocarcinoma: A retrospective analysis using the Mayo staging system. Medicine (Baltimore) Wang Z, Lv D, Yu H, Wang C, Peng Y. PMID: 42410830 [PubMed - indexed for MEDLINE]
	Laparoscopic versus open pancreaticoduodenectomy for non-pancreatic periampullary adenocarcinomas: study protocol for a multicentre randomised controlled trial in China. BMJ Open Li S, Pan S, Wang M, Huang X, Zhao W, Yu X, Chen X, Chen H, Dang X, Chen G, Wang L, An W, Zhang Q, Gao S, Guo S, Qin T, Zhang H, Qin R. PMID: 42409398 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers. J Egypt Natl Canc Inst Nisa FU, Ali M, Khan T, Lohana M, Asif A, Kumari N, Ali M. PMID: 42406230 [PubMed - indexed for MEDLINE]
	Peripheral hepatojejunostomy for unresectable malignant biliary obstruction: is it still a valid strategy? Langenbecks Arch Surg Fard-Aghaie MH, Stephan CH, Imdahl S, Stavrou GA, Laengle J, Wagner KC, Hackert T, Oldhafer KJ. PMID: 42406131 [PubMed - indexed for MEDLINE]
	Primary gallbladder melanoma - a rare entity or a diagnostic pitfall? Rom J Morphol Embryol Dan RG, Cozma GV, Moldoveanu AI, Orza, Mederle OA, Hu. PMID: 42402734 [PubMed - indexed for MEDLINE]
	Cholangiocarcinoma with metachronous urothelial malignancy as a rare manifestation of Lynch syndrome with no gastrointestinal tumour. BMJ Case Rep Joel S, Shah S. PMID: 42373201 [PubMed - indexed for MEDLINE]
	Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation. Med Petrelli F, Pesenti C, Cribiù FM, Arru M, Russo A, Viti M, Celotti A, Tomasello G, Ghidini A, Zaniboni A, Baiocchi G, Garrone O, Ghidini M. PMID: 42372729 [PubMed - indexed for MEDLINE]
	Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma. Cancer Med Chi Z, Chen L, Yang W, Huang N, Huang J, Chen F. PMID: 42366527 [PubMed - indexed for MEDLINE]
	Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis. Clin Exp Metastasis Vitale E, Maistrello L, Ciccimarra F, Guven DC, Sahin TK, Monteiro FSM, de Luca R, Scaramuzzi M, Delcuratolo S, Brunetti O, Rizzo A, Brandi G. PMID: 42366316 [PubMed - indexed for MEDLINE]
	Role of CD25hi CD45RA+ CD4 not Treg %T cell in mediating the effect of pyruvate fermentation to acetone on intrahepatic cholangiocarcinoma. Medicine (Baltimore) Chen J, Li H. PMID: 42363540 [PubMed - indexed for MEDLINE]
	The prognostic impact of microvascular invasion in patients with cholangiocarcinoma: A retrospective study. Medicine (Baltimore) Lee J, Jeong S, Lee DH, Park JS. PMID: 42363522 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 17506

Seite 1 von 876



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung